Sitagliptin + Metformin HydrochlorideDPP-4 Inhibitor’s combination (Antidiabetic Preparations) Indication: Management of type 2 diabetes mellitus. Dosage & Administration: Dose of this combination should be individualized on the basis of the patient’s current regimen, effectiveness, and tolerability while not exceeding the maximum recommended daily dose of 100 mg Sitagliptin and 2000 mg Metformin. Administer once daily […]